Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 1294 entries
View as:

An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

Phase: N/A Priority: Normal
NCT ID: NCT05621746 Org: User:
Start: 11/23/22 End: 06/30/26 Due: 06/30/27

Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH

Phase: N/A Priority: Normal
NCT ID: NCT01518166 Org: User:
Start: 05/31/06 End: 04/30/07 Due: 04/30/08

Safety of Recombinant Factor XIII (rFXIII) in Healthy Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01153997 Org: User:
Start: 06/30/10 End: 08/31/10 Due: 08/31/11

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01205724 Org: User:
Start: 09/30/10 End: 04/30/11 Due: 04/30/12

A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet

Phase: N/A Priority: Normal
NCT ID: NCT05429593 Org: User:
Start: 06/22/22 End: 04/13/23 Due: 04/13/24

A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)

Phase: N/A Priority: Normal
NCT ID: NCT05468632 Org: User:
Start: 07/05/22 End: 07/31/22 Due: 07/31/23

Safety of Treatment Initiation With Biphasic Insulin Aspart 30 in Hospitalised Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01565733 Org: User:
Start: 01/31/07 End: 07/31/07 Due: 07/31/08

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01751152 Org: User:
Start: 02/28/13 End: 12/31/14 Due: 12/31/15

Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02461589 Org: User:
Start: 09/21/15 End: 10/13/16 Due: 10/13/17

Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

Phase: N/A Priority: Normal
NCT ID: NCT00781937 Org: User:
Start: 10/30/08 End: 09/01/10 Due: 09/01/11

A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT05979428 Org: User:
Start: 08/07/23 End: 03/14/25 Due: 03/14/26

Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00959101 Org: User:
Start: 08/31/09 End: 10/31/09 Due: 10/31/10

Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01403025 Org: User:
Start: 07/19/11 End: 12/28/15 Due: 12/28/16

Observational Study to Evaluate the Safety of Levemir® in Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00659295 Org: User:
Start: 06/30/04 End: 03/31/10 Due: 03/31/11

A Trial Investigating NN1218 in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01121289 Org: User:
Start: 04/30/10 End: 07/31/10 Due: 07/31/11

Observational Study to Observe the Safety of Levemir® Treatment in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00735501 Org: User:
Start: 03/31/08 End: 05/31/10 Due: 05/31/11

A Research Study of How a New Medicine NNC0148-0287 C (Insulin 287) Works in the Body of People With Kidney Problems

Phase: N/A Priority: Normal
NCT ID: NCT03723785 Org: User:
Start: 11/09/18 End: 09/06/19 Due: 09/06/20

Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01486940 Org: User:
Start: 03/31/02 End: 10/31/02 Due: 10/31/03

A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study

Phase: N/A Priority: Normal
NCT ID: NCT03687827 Org: User:
Start: 10/02/18 End: 12/27/19 Due: 12/27/20

A Research Study Looking Into the Effect of Semaglutide and NNC0480 0389 on Blood Levels of a Birth Control Pill in Woman After Menopause

Phase: N/A Priority: Normal
NCT ID: NCT05153564 Org: User:
Start: 12/13/21 End: 09/01/22 Due: 09/01/23

Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

Phase: N/A Priority: Normal
NCT ID: NCT01110928 Org: User:
Start: 11/26/09 End: 11/12/18 Due: 11/12/19

A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05091073 Org: User:
Start: 12/09/21 End: 05/31/22 Due: 05/31/23

Observational Study on Efficacy, Safety and Convenience of Using Mixtard® 30 NovoLet® Alone or Combined With OHA in Treatment of Type 2 Diabetes in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01492166 Org: User:
Start: 11/30/06 End: 06/30/07 Due: 06/30/08

A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT04655690 Org: User:
Start: 11/09/20 End: 11/26/21 Due: 11/26/22

Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

Phase: N/A Priority: Normal
NCT ID: NCT01327924 Org: User:
Start: 04/30/11 End: 06/30/12 Due: 06/30/13